<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/034708BF-ABCD-4B6C-A875-B39F8041E295"><gtr:id>034708BF-ABCD-4B6C-A875-B39F8041E295</gtr:id><gtr:firstName>Declan</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Diver</gtr:surname><gtr:orcidId>0000-0001-6478-6020</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MC_PC_15009"><gtr:id>CA33D2A0-5F39-4738-A025-837996369893</gtr:id><gtr:title>Ozone destruction of biofilms for high level decontamination in healthcare</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MC_PC_15009</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Ozone is one of the most powerful biocidal agents known to science: bacteria, spores, viruses and biofilms are all susceptible to destruction by ozone. Anacail?s gaseous biocide technology delivers ozone on demand and in situ by using a cold plasma technique to create ozone from the surrounding air. No feedstock gases or additional chemicals are required, and the process can be performed remotely, through sealed packages. Anacail thus offers a unique capacity: end-point decontamination of goods in their final, sealed wrapping. In collaboration with Glasgow University we envisage application in healthcare services, focused on two separate, but linked strands: reservoirs of contaminated liquid (drains), and delicately structured and lumened endoscopes. The linking theme is gas penetration of otherwise inaccessible but contaminated structures: the drain pipe, and the exterior surface and lumens in endoscopes. Disinfection is required to prevent infection spread and cross-contamination.</gtr:technicalSummary><gtr:fund><gtr:end>2016-05-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>0</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Ozone, generated in situ in a sealed container from outside that container by the application of IP protected plasma technology, was applied to murine norovirus s99/RAW 264.7 cells under dirty conditions (ie in presence of standard soil 3g bovine albumin + 3g erythorcytes). We ahieved a &amp;gt;4 log10 reduction in viable virus concentration, after 100s treatment. This testing was carried out by the accredited lab Blu Test Laboratories.</gtr:description><gtr:id>6F26B288-5CEF-4C5D-B978-1214E5685638</gtr:id><gtr:impact>This verifies efficacy of our method in context of decontamination of drains</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Indirect plasma generated ozone as in vitro virucide: murine norovirus</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Ozone, generated in situ in a sealed container from outside that container by the application of IP protected plasma technology, was applied to Aspergillis basiliensis ATCC 16404 under dirty conditions (ie in presence of standard soil 3g bovine albumin + 3g erythorcytes). We ahieved a &amp;gt;4 log10 reduction in fungal concentration, after 100s treatment followed by 1 hour dwell time. This testing was carried out by the accredited lab Blu Test Laboratories.</gtr:description><gtr:id>EEAECC0C-3817-4418-8B07-4488C3C65678</gtr:id><gtr:impact>This success underlines the efficacy of the technology in decontaminating drains and lumens</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Indirect cold plasma efficacy as in vitro fungicide: Aspergillus brasiliensis</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Ozone, generated in situ in a sealed container from outside that container by the application of IP protected plasma technology, was applied to Salmonella enteritidic NCTC 13346, Listeria monocytogenes NCTC 7973, Escherichia coli 0157 NTCT 12900 and Clostridium difficile NCTC 11209 under dirty conditions (ie in presence of standard soil 3g bovine albumin + 3g erythorcytes). We ahieved a &amp;gt;5 log10 reduction in viable bacterial concentration on each separate sample, after 100s treatment. This testing was carried out by the accredited lab Blu Test Laboratories.</gtr:description><gtr:id>4473BC4D-3653-48A9-B220-AA66BB733997</gtr:id><gtr:impact>This underlines the efficacy of our novel plasma decontamination of drains and lumens</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Bactericidal efficacy of cold plasma generated ozone</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Cold plasma generated ozone used in both sealed package mode and drain cleaning mode to reduce the bioburden associated with inoculated Pseudomonas biofilms on various surfaces, including the interior of HDPE plumbing pipes</gtr:description><gtr:id>459C801B-77D2-42C9-9025-C2780E1378DB</gtr:id><gtr:impact>Testament to the efficacy of our approach in decontaminating real drains by using gaseous ozone generated in situ via a cold plasma.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Indirect cold plasma ozone efficacy as method for inactivating biofilm bioburden</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Ozone, generated in situ in a sealed container from outside that container by the application of IP protected plasma technology, was applied to Mycobacterium terrae under dirty conditions (ie in presence of standard soil 3g bovine albumin + 3g erythorcytes). We ahieved a &amp;gt;4 log10 reduction in viable virus concentration, after 100s treatment. This testing was carried out by the accredited lab Blu Test Laboratories.</gtr:description><gtr:id>0B5AD66A-8B4E-4047-AA47-11214682773A</gtr:id><gtr:impact>Testament to the in-vitro efficacy of our plasma technique for decontaminating drains and lumens</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Indirect cold plasma ozone efficacy in vitro as mycobactericide: Mycobacterium terrae</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15009</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>4CFCFE99-281F-452D-9C77-757ECDBEB0DC</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.3  Medical devices</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>